Immunotherapy combined with epidermal growth factor receptor-tyrosine kinase inhibitors in non-small-cell lung cancer treatment

Por Liang, Hongge, Liu, Xiaoyan, Wang, Mengzhao
Publicado no Onco Targets Ther (2018)

Clinicopathological features of lung cancer in patients with rheumatoid arthritis

Por Liu, Xiaoyan, Xu, Yan, Zhou, Qing, Chen, Minjiang, Liang, Hongge, Zhao, Jing, Zhong, Wei, Wang, Mengzhao
Publicado no J Thorac Dis (2018)

Clinical features and outcomes of ALK rearranged non‐small cell lung cancer with primary resistance to crizotinib

Por Ma, Di, Zhang, Yan, Xing, Puyuan, Hao, Xuezhi, Wang, Mengzhao, Wang, Yan, Shan, Li, Xin, Tao, Liang, Hongge, Du, Yang, Zhang, Zhaohui, Liang, Li, Li, Junling
Publicado no Thorac Cancer (2019)

Impact of crizotinib on long-term survival of ALK-positive advanced non-small-cell lung cancer: A Chinese multicenter cohort study

Por Xing, Puyuan, Ma, Di, Wang, Qiang, Hao, Xuezhi, Wang, Mengzhao, Wang, Yan, Shan, Li, Xin, Tao, Liang, Li, Liang, Hongge, Du, Yang, Zhang, Zhaohui, Li, Junling
Publicado no Chin J Cancer Res (2019)

Real‐world data on EGFR/ALK gene status and first‐line targeted therapy rate in newly diagnosed advanced non‐small cell lung cancer patients in Northern China: A prospective observ...

Por Liang, Hongge, Song, Xia, Zhang, Yuhui, Zhang, Shucai, Li, Fang, Fang, Jian, Li, Junling, Liang, Li, Nie, Ligong, Ma, Kewei, Zhang, Liangming, Wang, Xiaohong, Xu, Junjun, Wei, Yanxia, Wang, Jinghui, Song, Qi, Tian, Guangming, Mu, Yuxin, Gu, Yangchun, Yang, Lei, Sun, Ping, Zhong, Wei, Zhao, Jing, Xu, Yan, Chen, Minjiang, Wang, Mengzhao
Publicado no Thorac Cancer (2019)